BIOMAT Database Logo BIOMAT Database Logo

Drug interaction between sevelamer and cyclosporin. 2004

Miguel-Angel Guillen-Anaya, and Michel Jadoul

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D010760 Phosphorus Metabolism Disorders Disorders in the processing of phosphorus in the body: its absorption, transport, storage, and utilization. Disorder, Phosphorus Metabolism,Disorders, Phosphorus Metabolism,Metabolism Disorder, Phosphorus,Metabolism Disorders, Phosphorus,Phosphorus Metabolism Disorder
D011073 Polyamines Amine compounds that consist of carbon chains or rings containing two or more primary amino groups. Polyamine
D011095 Polyethylenes Synthetic thermoplastics that are tough, flexible, inert, and resistant to chemicals and electrical current. They are often used as biocompatible materials for prostheses and implants. Ethylene Polymers,Ethene Homopolymers,Homopolymers, Ethene,Polymers, Ethylene
D004066 Digestive System Diseases Diseases in any part of the GASTROINTESTINAL TRACT or the accessory organs (LIVER; BILIARY TRACT; PANCREAS). Digestive System Disorders,Hepatobiliary Diseases,Hepatobiliary Disorders,Digestive System Disease,Digestive System Disorder,Hepatobiliary Disease,Hepatobiliary Disorder,System Disorders, Digestive
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004852 Epoxy Compounds Organic compounds that include a cyclic ether with three ring atoms in their structure. They are commonly used as precursors for POLYMERS such as EPOXY RESINS. Epoxide,Epoxides,Epoxy Compound,Oxiranes,Compound, Epoxy,Compounds, Epoxy
D005260 Female Females

Related Publications

Miguel-Angel Guillen-Anaya, and Michel Jadoul
Drug interaction between sevelamer and cyclosporin.
March 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Miguel-Angel Guillen-Anaya, and Michel Jadoul
Drug interaction between sevelamer and cyclosporin.
July 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Miguel-Angel Guillen-Anaya, and Michel Jadoul
Drug interaction between sevelamer and furosemide.
October 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Miguel-Angel Guillen-Anaya, and Michel Jadoul
Drug interaction between midecamycin and cyclosporin.
January 1995, Nephron,
Miguel-Angel Guillen-Anaya, and Michel Jadoul
Drug Interaction Between Sevelamer and Levetiracetam: The First Clinical Experience.
August 2020, American journal of therapeutics,
Miguel-Angel Guillen-Anaya, and Michel Jadoul
Cyclosporin A and drug interaction.
January 1989, Advances in experimental medicine and biology,
Miguel-Angel Guillen-Anaya, and Michel Jadoul
Kidney graft dysfunction after drug interaction between clarithromycin and cyclosporin.
June 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Miguel-Angel Guillen-Anaya, and Michel Jadoul
Kidney graft dysfunction after drug interaction between miocamycin and cyclosporin.
January 1999, Transplant international : official journal of the European Society for Organ Transplantation,
Miguel-Angel Guillen-Anaya, and Michel Jadoul
Interaction between cyclosporin and chlorambucil.
September 1993, European journal of haematology,
Miguel-Angel Guillen-Anaya, and Michel Jadoul
Interaction between cyclosporin and fluoxetine.
August 1995, BMJ (Clinical research ed.),
Copied contents to your clipboard!